Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(100.0%)

5Total

N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06299514Not ApplicableRecruiting

RAFT - Pace &Ablate

Role: lead

NCT07205679Not Yet Recruiting

Cardiovascular Performance and Exercise Response in Patients With Persistent or Permanent Atrial Fibrillation and Heart Failure Pre and Post Cardioversion or Pace and Ablate

Role: lead

NCT06815783Not ApplicableActive Not Recruiting

Novel Approach to Conduction System Pacing With Use of Ultrasound

Role: lead

NCT05428787Not ApplicableActive Not Recruiting

Resynchronization in Patients With HF in AF Trial Undergoing Pace & AVNA Strategy With LBBAP Compared With BiV Pacing

Role: lead

NCT04858698Not ApplicableRecruiting

Reduction Or Elimination Of Radiation During Implantation of Cardiac Devices Using Ultrasound

Role: lead

NCT04842227Not ApplicableCompleted

Blocks Alternative to Sedation

Role: lead

All 6 trials loaded